Changing treatment paradigms for the management of inflammatory bowel disease.

about

Changing treatment paradigms for the management of inflammatory bowel disease.

Item

http://www.wikidata.org/entity/Q48537463

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh-hant

name

Changing treatment paradigms for the management of inflammatory bowel disease.

@en

Changing treatment paradigms for the management of inflammatory bowel disease.

@nl

type

Item

label

Changing treatment paradigms for the management of inflammatory bowel disease.

@en

Changing treatment paradigms for the management of inflammatory bowel disease.

@nl

prefLabel

Changing treatment paradigms for the management of inflammatory bowel disease.

@en

Changing treatment paradigms for the management of inflammatory bowel disease.

@nl

P1476

Changing treatment paradigms for the management of inflammatory bowel disease.

@en

P2093

Byong Duk Ye

http://www.w3.org/2001/XMLSchema#string

Jong Pil Im

http://www.w3.org/2001/XMLSchema#string

Joo Sung Kim

http://www.w3.org/2001/XMLSchema#string

You Sun Kim

http://www.w3.org/2001/XMLSchema#string

P275

Creative Commons Attribution-NonCommercial

P2860

Navigating the Microbial Basis of Inflammatory Bowel Diseases: Seeing the Light at the End of the Tunnel

Changing epidemiological trends of inflammatory bowel disease in Asia

Use of Thiopurines in Inflammatory Bowel Disease: A Consensus Statement by the Korean Association for the Study of Intestinal Diseases (KASID)

Understanding and Preventing the Global Increase of Inflammatory Bowel Disease.

Advances in Use of Endoscopy, Radiology, and Biomarkers to Monitor Inflammatory Bowel Diseases.

Disability due to Inflammatory Bowel Disease Is Correlated with Drug Compliance, Disease Activity, and Quality of Life

Management of Crohn's disease in Taiwan: consensus guideline of the Taiwan Society of Inflammatory Bowel Disease.

Review article: why, when and how to de-escalate therapy in inflammatory bowel diseases.

Quality of care in inflammatory bowel disease in Asia: the results of a multinational web-based survey in the 2(nd) Asian Organization of Crohn's and Colitis (AOCC) meeting in Seoul.

Early anti-TNF/immunomodulator therapy is associated with better long-term clinical outcomes in Asian patients with Crohn's disease with poor prognostic factors

P304

28-35

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.3904/KJIM.2017.400

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P5008

ScienceSource

P577

2017-12-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

2018-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29334728

http://www.w3.org/2001/XMLSchema#string

P921

inflammatory bowel diseases

P932

5768555

http://www.w3.org/2001/XMLSchema#string